Assessing tumor mutations to gain insight into base excision repair sequence polymorphisms and smoking in colon cancer

Cancer Epidemiology Biomarkers and Prevention

Volumn 18, Issue 12, 2009, Pages 3384-3388

  Curtin, Karen ^a   Samowitz, Wade S ^b   Wolff, Roger K ^a   Ulrich, Cornelia M ^c   Caan, Bette J ^d   Potter, John D ^c   Slattery, Martha L ^a,e  

^a UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c Fred Hutchinson Cancer Research Center   (United States)

^d DIVISION OF RESEARCH   (United States)

^e UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; DNA GLYCOSYLTRANSFERASE; K RAS PROTEIN; OXOGUANINE DNA GLYCOSYLASE; PROTEIN P53; UNCLASSIFIED DRUG; XRCC1 PROTEIN;

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CIGARETTE SMOKING; COLON CANCER; CONTROLLED STUDY; CPG ISLAND; EXCISION REPAIR; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE INSTABILITY; MISSENSE MUTATION; PRIORITY JOURNAL;

ADULT; AGED; CASE-CONTROL STUDIES; COLONIC NEOPLASMS; CPG ISLANDS; DNA GLYCOSYLASES; DNA METHYLATION; DNA REPAIR; DNA REPAIR ENZYMES; DNA-BINDING PROTEINS; FEMALE; GENOTYPE; HUMANS; MALE; MICROSATELLITE INSTABILITY; MIDDLE AGED; MUTATION; PHENOTYPE; POLYMORPHISM, GENETIC; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS B-RAF; RAS PROTEINS; RISK FACTORS; SMOKING; TUMOR SUPPRESSOR PROTEIN P53;

EID: 73349115207     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-09-0955     Document Type: Article

References (27)

1. Potter JD. Colorectal cancer: molecules and populations. J Natl Cancer Inst 1999;91:916-32.
2. Fortini P, Dogliotti E. Base damage and single-strand break repair: mechanisms and functional significance of short- and long-patch repair subpathways. DNA Repair (Amst) 2007;6:398-409.
3. Paz-Elizur T, Sevilya Z, Leitner-Dagan Y, Elinger D, Roisman LC, Livneh Z. DNA repair of oxidative DNA damage in human carcinogenesis: potential application for cancer risk assessment and prevention. Cancer Lett 2008;266:60-72.
4. Weiss JM, Goode EL, Ladiges WC, Ulrich CM. Polymorphic variation in hOGG1 and risk of cancer: a review of the functional and epidemiologic literature. Mol Carcinog 2005;42:127-41.
5. Kim JI, Park YJ, Kim KH, et al. hOGG1 Ser326Cys polymorphism modifies the significance of the environmental risk factor for colon cancer. World J Gastroenterol 2003;9:956-60.
6. Park HW, Kim IJ, Kang HC, et al. The hOGG1 Ser326Cys polymorphism is not associated with colorectal cancer risk. J Epidemiol 2007;17:156-60.
7. Naccarati A, Pardini B, Hemminki K, Vodicka P. Sporadic colorectal cancer and individual susceptibility: a review of the association studies investigating the role of DNA repair genetic polymorphisms. Mutat Res 2007;635:118-45.
8. Curtin K, Samowitz WS, Wolff RK, et al. MSH6 G39E polymorphism and CpG island methylator phenotype in colon cancer. Mol Carcinog 2009;48:989-94.
9. Samowitz WS, Curtin K, Wolff RK, et al. The MLH1-93 G>A promoter polymorphism and genetic and epigenetic alterations in colon cancer. Genes Chromosomes Cancer 2008;47:835-44.
10. Slattery ML, Curtin K, Anderson K, et al. Associations between cigarette smoking, lifestyle factors, and microsatellite instability in colon tumors. J Natl Cancer Inst 2000;92:1831-6.
11. Slattery ML, Anderson K, Curtin K, et al. Lifestyle factors and Ki-ras mutations in colon cancer tumors. Mutat Res 2001;483:73-81.
12. Slattery ML, Curtin K, Ma K, et al. Diet activity, and lifestyle associations with p53 mutations in colon tumors. Cancer Epidemiol Biomarkers Prev 2002;11:541-8.
13. Samowitz WS, Albertsen H, Sweeney C, et al. Association of smoking, CpG island methylator phenotype, and V600E BRAF mutations in colon cancer. J Natl Cancer Inst 2006;98:1731-8.
14. Curtin K, Samowitz WS, Wolff RK, Herrick J, Caan BJ, Slattery ML. Somatic alterations, metabolizing genes and smoking in rectal cancer. Int J Cancer 2009;125:158-64.
15. Slattery ML, Potter J, Caan B, et al. Energy balance and colon cancer-beyond physical activity. Cancer Res 1997;57:75-80.
16. Edwards S, Slattery ML, Mori M, et al. Objective system for interviewer performance evaluation for use in epidemiologic studies. Am J Epidemiol 1994;140:1020-8.
17. Bigler J, Ulrich CM, Kawashima T, Whitton J, Potter JD. DNA repair polymorphisms and risk of colorectal adenomatous or hyperplastic polyps. Cancer Epidemiol Biomarkers Prev 2005;14:2501-8.
18. Samowitz WS, Albertsen H, Herrick J, et al. Evaluation of a large, population-based sample supports a CpG island methylator phenotype in colon cancer. Gastroenterology 2005;129:837-45.
19. Samowitz WS. The CpG island methylator phenotype in colorectal cancer. J Mol Diagn 2007;9:281-3.
20. Slattery ML, Curtin K, Ma K, Schaffer D, Potter J, Samowitz W. GSTM-1 and NAT2 and genetic alterations in colon tumors. Cancer Causes Control 2002;13:527-34.
21. Burton P, Gurrin L, Sly P. Extending the simple linear regression model to account for correlated responses: an introduction to generalized estimating equations and multi-level mixed modelling. Stat Med 1998;17: 1261-91.
22. Kuss O, McLerran D. A note on the estimation of the multinomial logistic model with correlated responses in SAS. Comput Methods Programs Biomed 2007;87:262-9.
23. Slattery ML, Curtin K, Wolff RK, et al. A comparison of colon and rectal somatic DNA alterations. Dis Colon Rectum 2009;52:1304-11.
24. Sweeney C, Boucher KM, Samowitz WS, et al. Oncogenetic tree model of somatic mutations and DNA methylation in colon tumors. Genes Chromosomes Cancer 2009;48:1-9.
25. Potter JD, Bigler J, Fosdick L, et al. Colorectal adenomatous and hyperplastic polyps: smoking and N-acetyltransferase 2 polymorphisms. Cancer Epidemiol Biomarkers Prev 1999;8:69-75.
26. Vaughn CP, Wilson AR, Samowitz WS. Quantitative Evaluation of CpG Island Methylation in Hyperplastic Polyps. Mod Pathology 2009, Oct. 23 [Epub ahead of print].
27. Sliwinski T, Krupa R, Wisniewska-Jarosinska M, et al. Common polymorphisms in the XPD and hOGG1 genes are not associated with the risk of colorectal cancer in a Polish population. Tohoku J Exp Med 2009; 218:185-91.